Sökning: WFRF:(Freund Levi Yvonne 1956 ) >
Low background and ...
Low background and high contrast PET imaging of amyloid-β with [11C]AZD2995 and [11C]AZD2184 in Alzheimer's disease patients
-
- Forsberg, Anton (författare)
- Karolinska Institutet
-
- Juréus, Anders (författare)
- Neuroscience Research & Therapy Area, AstraZeneca Research & Development, Södertälje, Sweden
-
- Cselényi, Zsolt (författare)
- Karolinska Institutet
-
visa fler...
-
- Eriksdotter, Maria (författare)
- Karolinska Institutet
-
- Freund-Levi, Yvonne, 1956- (författare)
- Clinical Geriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden; ; Department of Geriatric Medicine, Karolinska University Hospital, Stockholm, Sweden
-
- Jeppsson, Fredrik (författare)
- Neuroscience Research & Therapy Area, AstraZeneca Research & Development, Södertälje, Sweden; Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden
-
- Swahn, Britt-Marie (författare)
- Neuroscience Research & Therapy Area, AstraZeneca Research & Development, Södertälje, Sweden
-
- Sandell, Johan (författare)
- Neuroscience Research & Therapy Area, AstraZeneca Research & Development, Södertälje, Sweden
-
- Julin, Per (författare)
- Neuroscience Research & Therapy Area, AstraZeneca Research & Development, Södertälje, Sweden
-
- Schou, Magnus (författare)
- Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden; AstraZeneca Translational Sciences Centre, PET CoE, Department of Clinical Neuroscience, Karolinska Institutet, Karolinska Hospital, Stockholm, Sweden
-
- Andersson, Jan (författare)
- Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
-
- Johnström, Peter (författare)
- Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden; AstraZeneca Translational Sciences Centre, PET CoE, Department of Clinical Neuroscience, Karolinska Institutet, Karolinska Hospital, Stockholm, Sweden
-
- Varnäs, Katarina (författare)
- Karolinska Institutet
-
- Halldin, Christer (författare)
- Karolinska Institutet
-
- Farde, Lars (författare)
- Karolinska Institutet
-
- Svensson, Samuel (författare)
- Neuroscience Research & Therapy Area, AstraZeneca Research & Development, Södertälje, Sweden
-
visa färre...
-
(creator_code:org_t)
- 2013-01-17
- 2013
- Engelska.
-
Ingår i: European Journal of Nuclear Medicine and Molecular Imaging. - : Springer-Verlag New York. - 1619-7070 .- 1619-7089. ; 40:4, s. 580-593
- Relaterad länk:
-
https://doi.org/10.1...
-
visa fler...
-
https://link.springe...
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
http://kipublication...
-
visa färre...
Abstract
Ämnesord
Stäng
- PURPOSE: The aim of this study was to evaluate AZD2995 side by side with AZD2184 as novel PET radioligands for imaging of amyloid-β in Alzheimer's disease (AD).METHODS: In vitro binding of tritium-labelled AZD2995 and AZD2184 was studied and compared with that of the established amyloid-β PET radioligand PIB. Subsequently, a first-in-human in vivo PET study was performed using [(11)C]AZD2995 and [(11)C]AZD2184 in three healthy control subjects and seven AD patients.RESULTS: AZD2995, AZD2184 and PIB were found to share the same binding site to amyloid-β. [(3)H]AZD2995 had the highest signal-to-background ratio in brain tissue from patients with AD as well as in transgenic mice. However, [(11)C]AZD2184 had superior imaging properties in PET, as shown by larger effect sizes comparing binding potential values in cortical regions of AD patients and healthy controls. Nevertheless, probably due to a lower amount of nonspecific binding, the group separation of the distribution volume ratio values of [(11)C]AZD2995 was greater in areas with lower amyloid-β load, e.g. the hippocampus.CONCLUSION: Both AZD2995 and AZD2184 detect amyloid-β with high affinity and specificity and also display a lower degree of nonspecific binding than that reported for PIB. Overall [(11)C]AZD2184 seems to be an amyloid-β radioligand with higher uptake and better group separation when compared to [(11)C]AZD2995. However, the very low nonspecific binding of [(11)C]AZD2995 makes this radioligand potentially interesting as a tool to study minute levels of amyloid-β. This sensitivity may be important in investigating, for example, early prodromal stages of AD or in the longitudinal study of a disease modifying therapy.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Radiologi och bildbehandling (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Radiology, Nuclear Medicine and Medical Imaging (hsv//eng)
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Neurologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Neurology (hsv//eng)
- MEDICIN OCH HÄLSOVETENSKAP -- Medicinska och farmaceutiska grundvetenskaper -- Farmakologi och toxikologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Basic Medicine -- Pharmacology and Toxicology (hsv//eng)
Nyckelord
- Alzheimer's disease
- Amyloid-beta imaging
- [C-11]AZD2995
- [C-11]AZD2184
- PET imaging
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Forsberg, Anton
-
Juréus, Anders
-
Cselényi, Zsolt
-
Eriksdotter, Mar ...
-
Freund-Levi, Yvo ...
-
Jeppsson, Fredri ...
-
visa fler...
-
Swahn, Britt-Mar ...
-
Sandell, Johan
-
Julin, Per
-
Schou, Magnus
-
Andersson, Jan
-
Johnström, Peter
-
Varnäs, Katarina
-
Halldin, Christe ...
-
Farde, Lars
-
Svensson, Samuel
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Radiologi och bi ...
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Neurologi
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Medicinska och f ...
-
och Farmakologi och ...
- Artiklar i publikationen
-
European Journal ...
- Av lärosätet
-
Örebro universitet
-
Karolinska Institutet